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Abstract
Background: Mutations in the SHOX gene are responsible for Leri-Weill Dyschondrosteosis, a disorder characterised by
mesomelic limb shortening. Recent investigations into regulatory elements surrounding SHOX have shown that deletions of
conserved non-coding elements (CNEs) downstream of the SHOX gene produce a phenotype indistinguishable from Leri-
Weill Dyschondrosteosis. As this gene is not found in rodents, we used zebrafish as a model to characterise the expression
pattern of the shox gene across the whole embryo and characterise the enhancer domains of different CNEs associated with
this gene.
Methodology/Principal Findings: Expression of the shox gene in zebrafish was identified using in situ hybridization, with
embryos showing expression in the blood, putative heart, hatching gland, brain pharyngeal arch, olfactory epithelium, and
fin bud apical ectodermal ridge. By identifying sequences showing 65% identity over at least 40 nucleotides between Fugu,
human, dog and opossum we uncovered 35 CNEs around the shox gene. These CNEs were compared with CNEs previously
discovered by Sabherwal et al., resulting in the identification of smaller more deeply conserved sub-sequence. Sabherwal
et al.’s CNEs were assayed for regulatory function in whole zebrafish embryos resulting in the identification of additional
tissues under the regulatory control of these CNEs.
Conclusion/Significance: Our results using whole zebrafish embryos have provided a more comprehensive picture of the
expression pattern of the shox gene, and a better understanding of its regulation via deeply conserved noncoding elements.
In particular, we identify additional tissues under the regulatory control of previously identified SHOX CNEs. We also
demonstrate the importance of these CNEs in evolution by identifying duplicated shox CNEs and more deeply conserved
sub-sequences within already identified CNEs.
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Introduction
Mutations in the short stature HOX gene, SHOX have been
shown to be responsible for the dominantly inherited skeletal
dysplasia Leri-Weill Dyschondrosteosis (LWD). LWD is charac-
terised by disproportionate short stature with mesomelic limb
shortening [1]. This disorder is the result of haploinsufficiency of
the SHOX gene, which is found in the pseudoautosomal region at
the telomere of the short arm of the X and Y chromosomes. SHOX
was discovered when looking for a Turner syndrome short-stature
gene in the Xp-Yp pseudoautosomal region (PAR1). Genes within
this region escape X-inactivation in females and participate in
obligate recombination during male meiosis. This results in LWD
being an apparently ‘‘autosomal’’ dominant disorder. Turner
syndrome is also characterised by short stature but is frequently
associated with a variable spectrum of somatic features, including
ovarian failure, heart and renal abnormalities, micrognathia,
cubitus valgus, high-arched palate, short metacarpals and
Madelung deformity [2,3]. SHOX is thus haploinsufficient in
females with 45,X Turner syndrome, accounting for approxi-
mately two-thirds of the characteristic growth deficit [4,5].
In human, the SHOX gene has two isoforms, with SHOXA
expressed in skeletal muscle, placenta, pancreas, heart and bone
marrow fibroblasts and SHOXB transcripts restricted to fetal
kidney, skeletal muscle and bone marrow fibroblasts [2]. In the
whole embryo, SHOXA has been shown to be expressed in the
central part of both upper and lower limbs (UL and LL), and in
the first pharyngeal arch (1st PA) [6] of a lateral, sagittal section of
a CS16 human embryo.
In cases such as these, it would be expected that a mouse model
would be used to further characterise the function of the gene but,
interestingly, this gene is not found in rodents. Therefore, the only
non-human research into this gene has been carried out in chick.
In situ hybridisation in whole chick embryos has shown expression
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developing chick embryo [7], with some expression in the
mesenchyme overlaying the eye. Closer inspection of the
expression in the limb found SHOX expressed in the central
region of the early limb bud, leaving a rim of non-expressing cells
around it. Sectioning showed the expression to be in a thin layer of
mesenchyme, just under the ectoderm. Later stages showed
expression is restricted to the proximal two thirds of the limb bud
and eventually becomes expressed in the digital rays, with stronger
expression dorsally, and stripes of expression in the muscle and
strong expression under the dermis.
A second member of the SHOX family, SHOX2, is present in the
rodent lineage and also shows expression in the limb in addition to
other tissues. In human, SHOX2 has a subtly different expression
pattern to SHOX. Where SHOX expression in the human limb is
observed as a band across the limb and then around the pre-
cartilaginous structure of the bones of the elbow joint, with
expression becoming confined to the middle portion of the arm,
most highly in the perichondrial tissue. The expression of SHOX2
is seen in the dorsal region of the lower limb. In the forelimbs
SHOX2 expression is more proximal to that of SHOX and is also
observed in the dorsal root ganglia [8]. In mouse limb Shox2
expression is observed in mesodermal cells on the dorsal side of the
limb bud with expression intensifying in the mesoderm of the
progress zone and in undifferentiated mesoderm condensing
around the ossification centres. It is also found in ectodermal
tissue including brain, spinal cord, and ganglia (in otic) with the
highest levels of expression found in mesodermal tissues of the face
involved in nose and palate formation, the developing eyelid and
tissue surrounding the optic nerve, as well as in the developing
heart mesoderm, although heart expression is restricted to the
developing outflow track and the developing aorta [9].
Investigations into regulatory elements around SHOX have
found that deletion of conserved non-coding elements (CNEs)
downstream of the SHOX gene produces a phenotype indistin-
guishable from patients with mutations in the SHOX coding region
and so resulting in Leri-Weill Dyschondrosteosis. These CNEs
were electroporated into chick limbs and shown to drive
expression in the limb bud [10]. This assay, by its nature, will
only show expression in the limb bud. By using zebrafish as a
model, we aimed to characterise the expression pattern of the shox
gene across the whole embryo and also characterise the enhancer
domains of different CNEs associated with this gene. Finally, by
using elements from both Fugu and human we aim to develop a
better understanding of the evolution of these CNEs. This will
result in a more comprehensive understanding of the range of
expression in this gene, and the regulatory elements that are, at
least in part, responsible for directing that expression.
Results
Identification of CNEs at the shox locus
Conserved non-coding elements (CNEs) around the shox gene
were identified from a multiple alignment of the human, dog,
opossum and Fugu loci using MLAGAN [11]. These elements were
submitted to the CONDOR database [12] and given unique
identifiers, for example CRCNE00011095. Table 1 shows the
location of these CNEs in the human genome. Sabherwal et al.
[10] also identified CNEs downstream of the human SHOX gene,
within a 200 kb minimally deleted region associated with short
stature. Sabherwal et al. named these CNE4, CNE5, CNE6,
CNE7, CNE8 and CNE9, with CNE7, CNE8 and CNE9 being
shown to be deleted in patients with short stature. These
Sabherwal CNEs are longer than those identified in the
CONDOR database, such that each one can encompass an area
that includes multiple CONDOR CNEs. This is illustrated in
table 1, where, for example, Sabherwal’s CNE5 encompasses
CONDOR CNEs CRCNE00011075, CRCNE00011096,
CRCNE00011097, CRCNE00011098 and CRCNE00011099.
Table 1. Positions of CNEs found around the Human shox
gene using Human GRCh37 Ensembl release 61 (Feb 2011).
Human genomic
Condor CNE ID co-ordinates Sabherwal CNEs
CRCNE00011081 395932–396139
CRCNE00011074 398484–398605
CRCNE00011082 398646–398808
CRCNE00011083 421661–421749
CRCNE00011084 421789–421848
CRCNE00011085 433506–433625
CRCNE00011139 443510–443605
CRCNE00011086 455000–455084
CRCNE00011088 460789–460848
CRCNE00011089 516667–516966
SHOX Gene 585079–620146
CRCNE00011090 591474–591537
CRCNE00011115 598067–598108
CRCNE00011091 598664–598921
CRCNE00011094 612250–612333
CRCNE00011095 714364–714449 CNE4
CRCNE00011075 750835–750884 CNE5
CRCNE00011096 751022–751081
CRCNE00011097 751185–751471
CRCNE00011098 751521–751685
CRCNE00011099 751698–751757
CRCNE00011100 766109–766197 CNE6
CRCNE00011101 780784–780955 CNE7
CRCNE00011102 781023–781132
CRCNE00011103 811745–812051 CNE8
CRCNE00011104 835191–835339 CNE9
CRCNE00011105 835390–835434
CRCNE00011106 866772–866831
CRCNE00011107 934004–934039
CRCNE00011108 934182–934302
CRCNE00011109 963804–963863
CRCNE00011110 995756–995967
CRCNE00011111 1194952–1194993
CRCNE00011112 1199641–1199687
CRCNE00011113 1211415–1211449
CRCNE00011114 1211533–1211776
Figure 1: Schematic map of the positions of CNEs around the shox gene. Blue
CNEs are duplicated with the shox2 gene. A blue box represent those CNEs in
the Sabherwal et al. CNE4 region, a red box shows those CNEs in Sabherwal
et al. CNE5 region, a cream box shows those CNEs in Sabherwal et al. CNE6
region, a green box shows those CNEs in Sabherwal et al. CNE7 region, a brown
box shows those CNEs in Sabherwal et al. CNE8 region and a green box shows
those CNEs in Sabherwal et al. CNE9 region.
CNEs in bold are duplicated around the shox2 gene.
doi:10.1371/journal.pone.0021498.t001
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the orthologous Fugu (fCNE) region in the zebrafish embryo.
shox gene expression in zebrafish
Humans generate two isoforms of the SHOX gene (figure 1A),
which have different expression patterns [2]. Zebrafish appears to
have only one isoform (figure 1). Evidence of the zebrafish shox
gene comes from zebrafish specific ESTs and mRNA (figure 1), as
well as protein homology with mouse and human proteins. The
second human isoform includes a downstream exon that does not
appear, based on homology, to be present in zebrafish.
Expression of the zebrafish shox gene can be detected at
24 hours post fertilisation (hpf) in the blood (BL), putative heart,
hatching gland (HG) and brain, along with some non-specific
expression (figure 2A). By 72 hpf, shox expression is more specific
and can be detected in the hatching gland (HG) (figure 2B), the
pharyngeal arch (PA) (figure 2C), the olfactory epithelium (OP)
(figure 2D, 2E), the putative heart (PH) (figure 2D) and the fin bud
apical ectodermal ridge (FB) (figure 2E, 2F).
Comparison of enhancer activity of Fugu and human
CNEs in zebrafish embryos
At both day 2 and day 3, Sabherwal’s CNE4 drives reporter
expression in fin, the cardiovascular system, brain, skin, muscle
and notochord, using either human or Fugu elements. Additionally,
the human element drives expression in the ear at day 2 and day 3
(figure 3).
Both human and Fugu versions of Sabherwal’s CNE5 drive
expression in the brain, skin, heart and fins. In addition, the Fugu
element drives some expression in the ear, while the human
element drives expression in the muscle, notochord and eye
(figure 4).
Sabherwal’s human CNE9 predominantly drives expression in
the eye at both day 2 and day 3 whereas the Fugu element drives
expression mostly in the brain at these time points. Human and
Fugu elements drive expression in the fin and blood (figure 5).
Fugu CNE6 drives expression predominantly in muscle, skin and
fin, while Sabherwal’s human CNE6 drives expression in a more
diverse array of tissues; in particular heart and ear at day 2 and
muscle, ear, eye and heart at day 3 (figure 6).
Sabherwal’s CNE7 drives expression in brain, fin and the
cardiovascular system with both human and Fugu versions of the
CNE. Additionally human CNE7 at day 2 drives expression in the
skin (figure 7).
While Sabherwal’s CNE8 drives expression in both species in
skin, fin, CNS and muscle, the human element also drives
expression in heart, while the Fugu CNE drives expression in the
ear and eye (figure 8).
Comparison of hCRCNE00011095 and fCRCNE00011095
with hCNE4 and fCNE4
From the alignments in MLAGAN, smaller, more deeply
conserved elements can be identified within the larger Sabherwal
regions (Table 1). We investigated whether these direct more
Figure 1. Comparison of zebrafish and human shox gene and protein alignments: (A) Screenshot of Otterlace annotation software
used by the Wellcome Trust Sanger Institute to manually annotate the human and zebrafish genome for the Vega and Ensembl
genome browsers. Protein evidence is shown in blue, EST evidence is shown in purple, and mRNA evidence is shown in brown with the boxes
denoting exons. Human and zebrafish shox gene coding variants are shown as green and red boxes with green denoting coding areas and red
denoting non-coding parts. (B) Protein alignment comparing the zebrafish protein (uniprot ID Q3B7G6) with the human protein isoforms (uniprot ID
015266 and 015266-2). Separate exons are coloured differently.
doi:10.1371/journal.pone.0021498.g001
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Sabherwal’s larger elements might introduce noise or CNE non-
specific expression patterns.
By comparing Sabherwal’s human CNE4 with the our smaller
CNE hCRCNE00011095, we found that our hCRCNE0001-
11095 drives less expression (28 out of 276 embryos at day 2, 18
out of 249 at day 3) than Sabherwal’s hCNE4 (49 out of 243
embryos at day 2, 42 out of 236 embryos at day 3). Most of this
expression is observed in skin, with some additional expression in
fin, muscle and heart. This expression pattern is more cell type
specific than Sabherwal’s larger CNE (figure 3). In Fugu, our
smaller CNE fCRCNE00011095 showed no expression at either
time point (out of 121 embryos at day 2 and 111 at day 3).
Duplicated CNEs in shox2
Human SHOX locus CNEs with CONDOR IDs CRCNE-
00011085, CRCNE00011098, CRCNE00011094, CRCNE000-
11104, CRCNE00011110 and CRCNE00011111 (table 1) are
duplicated around the human SHOX2 locus. One copy of these
CNEs can also be found in rodents around the Shox2 locus as there
is no shox gene in these animals. This reflects the ancestral
origins of not only the genes but some of their regulatory elements
[13,14]
Discussion
Mutations in the SHOX gene and deletions of conserved non-
coding elements (CNEs) downstream of the SHOX gene have been
shown to be responsible for the dominantly inherited skeletal
dysplasia Leri-Weill Dyschondrosteosis (LWD) [1]. Assessing the
function of these CNEs relies on accurate methods of delineating
the sequences involved. Goode et al (2011) have recently shown
that short flanking sequences around a CNE can have a profound
impact on CNE function and, therefore, have cautioned that
CNEs should be accurately delineated before being used in studies
[15]. It is therefore important to understand the limits of a CNE
and how a study defines them. Sabherwal et al. [10] defined their
CNEs by comparing the human and chicken genome and
identifying regions with over 70% identity over greater than
200 bp of sequence. Six of those regions show identities of around
80% over .400 bp of sequence between human and chicken. Our
analysis uses 65% identity over at least 40 bp between Fugu and
human, resulting in the identification of shorter regions of much
more deeply conserved sequence. Our results in the zebrafish
embryo have shown that Sabherwal’s CNE4 drives reporter
expression in a variety of tissues, compared to the more deeply
conserved sub-sequence, CRCNE000111095, which fails to drive
expression when using the Fugu element, but drives primarily fin
expression when using the human element. When taking into
account Goode et al.’s caution this would suggest that the more
deeply conserved sub-sequence, CRCNE000111095 may show a
more accurate representation of the function of the CNE with this
CNE being responsible for enhancing limb development in human
but having little enhancer activity in Fugu [15].
When comparing these data, it should also be noted that the
zebrafish whole embryo system we have employed is very different
from the chick limb electroporation system used by Sabherwal
et al. [10]. Using the whole embryo permits the identification of
reporter expression in any tissue whereas electroporation of the
element and promoter into the chick limb bud will only detect
expression in that particular tissue or region [11]. Thus the chick
system is ideal for quickly determining if an element drives
Figure 2. Shox gene expression in whole zebrafish embryos: 24 hpf embryo (HG=hatching gland) (A), view of hatching gland in
72 hpf embryo HG=hatching gland (B), close up of head region showing pharyngeal arch (PA) 72 hpf embryo (C), ventral view of
72 hpf embryo showing olfactory pits (OP) and putative heart (PH) (D), view of the pectoral fin (PF) in 72 hpf embryo (E) and dorsal
view of pectoral fins (PF) in 72 hpf embryo (F).
doi:10.1371/journal.pone.0021498.g002
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where else in the animal the CNE might be functional. Rodent
models have commonly been employed to identify expression in
whole embryos but SHOX is absent from the rodent lineage. This
has led us to investigate the role of shox and its accompanying
CNEs in zebrafish.
To this end, we examined the expression pattern of the shox
gene in 24 hpf and 72 hpf zebrafish embryos. Our results show
that shox gene expression can be seen at 24 hpf in the putative
heart, hatching gland and brain while at 72 hpf expression persists
in the hatching gland (HG figure 2B) and putative heart (PH
figure 2D) but is also seen in the pharyngeal arches (PA figure 2C),
the olfactory epithelium (OP figure 2D, 2E) and the fin bud apical
ectodermal ridge (PF figure 2F). It is interesting to note that
human SHOX CNEs drive reporter expression in other tissues, as
shox gene expression in the whole human embryo has only been
identified in the limbs and the first pharyngeal arch [6]. However,
in chick, SHOX gene expression is more widespread than just limb
buds and pharyngeal arch and includes the neural tube, muscle
and the mesenchyme overlaying the eye [7,10].
Human, zebrafish and chick all show SHOX gene expression in
limb, with all of the human elements, as described by Sabherwal
et al. [10], when injected into whole zebrafish embryos, driving
some fin expression. The difference between our results which
show expression in not just the pectoral fin (considered to be most
related to human limb [16]) but other fin structures and those of
Sabherwal et al. can be accounted for if we separate expression
seen in the pectoral fin (an example of paired fins) from that
observed in the caudal fin (an example of the median fin). The
development of these fins has been shown to be different, with the
median fins developing directly from the epidermal fold
surrounding the caudal half of the young larvae, also called the
median fin fold [17]. The paired fins arise from a local
proliferation of the lateral plate mesoderm to form the fin bud
[16] but the exoskeleton (the fin rays) eventually develops within
an epidermal fin fold, in a process that resembles the development
of the median fins from the median fin fold [17]. It is therefore
probably more accurate to compare the pectoral fin buds with
human limb buds, as early fish fin buds and tetrapod limb buds
show morphological resemblances. They also both contain similar
signalling centres such as the zone of polarizing activity (ZPA) in
the posterior mesenchyme, the apical ectoderm ectodermal ridge
(AER) and the ventral ectoderm [16,18–22]. However, the AER of
the tetrapod limb progressively degenerates during development,
whereas the zebrafish apical ectoderm will form an elongated fin
fold in which the external part of the fin, including the fin rays will
eventually develop [16,23]. Therefore it may be more accurate
when comparing our findings with those of Sabherwal et al. to
consider all fin expression. Except that, if we do assume that the fin
buds are a more appropriate model for human limb development,
it can be seen that hCNE4 hCNE5 and hCNE9 are the only
elements that show pectoral fin expression.
Figure 3. Composite overview of GFP expression patterns induced by shox CNE4. Expression pattern in Fugu CNE4 at day 2 (n=37/180)
and at day 3 (n=35/174). Expression pattern in human CNE4 at day 2 and at day 3 (n=42/236). Expression pattern in human CR00011095 day 2
(n=28/276) and at day 3 (n=18/249). Fugu CR00011095 showed no expression on day 2 (0/121) and day 3 (n=0/111). F=Forebrain, M=Midbrain,
H=Hindbrain, SC=Spinal cord, ON=Other Neurons, Ey=Eye, Ea=Ear, N=Notochord, M=Muscle, B=Blood, H=Heart, S=Skin, F=Fin, O=Other.
doi:10.1371/journal.pone.0021498.g003
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explain some differences between our results and those seen by
Sabherwal et al. [10]. However, it is interesting to note that all the
human CNEs we tested drive caudal fin expression. This may well
be accounted for by the fact that the assay was performed in
zebrafish and the regulatory machinery may be similar between
paired and medial fin development in early zebrafish develop-
ment. Therefore, we cannot overlook the fact that, despite their
different embryonic origins, paired and median fins may utilize a
common suite of developmental mechanisms. Freitas et al. [24]
looked at lampreys, which diverged from the lineage leading to
gnathostomes before the origin of paired appendages. They
showed that lamprey median fins also develop from somites and
express orthologous of hox and tbx genes, which are important in
limb development. They suggest that the molecular mechanisms
for fin development originated in the somitic mesoderm of early
vertebrates, and that the origin of paired appendages was
associated with redeployment of these mechanisms to lateral plate
mesoderm. They argue it is possible that the mechanisms of fin
and limb development were established in median fin folds, even
before the origin of vertebrates [24]. In order to investigate the
evolution of these CNEs, we tested homologous CNE regions from
both the Fugu and human genomes in zebrafish embryos. From
this we can see that in general, patterns of reporter gene expression
in zebrafish caudal or paired fins is similar whether injecting Fugu
or human CNEs, suggesting that CNE function in these
appendages remains similar between Fugu and human.
In addition to the limb/fin expression seen in zebrafish, human
and chick, shox CNEs drive expression in predominantly the same
tissues that show shox gene expression. For example, much of the
CNE expression seen in all the embryos is attributed to areas
labelled as unspecified cells, which include cells of the hatching
gland and the pharyngeal arch tissues, which also show shox gene
expression in the zebrafish embryo. However, it is perhaps not
surprising there should be expression in both the limb/fin and the
pharyngeal arches, as these are not only the only tissues to show
shox expression in human but Gillis et al. [25] have recently
demonstrated that shared developmental mechanisms pattern the
vertebrate gill arch and paired fin skeletons, which might explain
the shox expression pattern seen in zebrafish and human [25].
A key area of SHOX gene expression, from a human disease
context, is in the brain and consequently the identification of
SHOX CNEs that drive expression in the brain (CNE4, CNE5,
CNE6 and CNE7) is of significance. In clinical studies, there has
been some association between Leri-Weill Dyschondrosteosis
(LWD) and mental retardation. Shears et al. [1] noted learning
Figure 4. Composite overview of GFP expression patterns induced by shox CNE5. Expression pattern in human CNE5 at day 2 (n=37/148)
and at day 3 (n=36/137). Expression pattern in Fugu CNE5 at day 2 (n=45/77) and at day 3 (n=46/64). F=Forebrain, M=Midbrain, H=Hindbrain,
SC=Spinal cord, ON=Other Neurons, Ey=Eye, Ea=Ear, N=Notochord, M=Muscle, B=Blood, H=Heart, S=Skin, F=Fin, O=Other.
doi:10.1371/journal.pone.0021498.g004
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suggested that this might be explained by deletion of contiguous
genes, since the responsible deletion encompassing the SHOX locus
extended into the X-specific region. In Spranger et al. [26] a male
patient with LWD, mental retardation, myoclonic epilepsy and
chondrodysplasia punctata was described. Molecular mapping
showed the maternally-derived deletion included SHOX, ARSE
(the gene mutated in X-linked chondrodysplasia punctata) and the
putative mental retardation locus mental retardation, X-linked 49
(MRX49). Therefore, it is possible that the reporter expression seen
in other tissues such as the brain that we see in our results (figure 4,
figure 5, figure 7 and figure 8) and Sabherwal et al. report in their
discussion might be due to these CNEs acting as regulatory inputs
for other genes in the PAR1 region rather than SHOX. If they are
indeed used only to regulate SHOX, it leads to the question why
SHOX disruption in human patients does not show abnormalities
in these tissues. A possible explanation is that these patients are
haploinsufficient and not completely null for SHOX and that
those embryos which are complete nulls are spontaneously
aborted. Haploinsufficient patients might retain sufficient SHOX
to form most tissues but not enough for full limb length. Robertson
et al. [27] reported a patient homozygous for SHOX but who also
showed mental retardation. Unfortunately one of the deletions
again extended into the PAR1 region but not the X-specific
region, leading to their suggestion of another possible mental
retardation, X locus in the PAR1 region [27]. A later study by
Zinn et al. [28] found that complete SHOX deficiency causes
Langer mesomelic dysplasia; displaying a more severe form of limb
shortening and dwarfism than LWD. However, the authors note
that none of the Langer patients were homozygous for complete
SHOX gene deletions. Zinn et al. [28] have also suggested that this
discrepancy could be accounted for if none of the patients were
truly null for SHOX activity, which could be associated with poor
viability. They state that one subject is heterozygous for a complete
SHOX deletion and a frameshift which truncates the protein after
only 13 amino acids of the homeodomain and is thus likely
homozygous null for SHOX [28]. Thirteen amino acids of the
homeodomain would probably make the gene product long
enough that there is no re-initiation further along the gene (thus no
truncated but viable protein) [29] so it would make the gene
subject to nonsense-mediated decay [30]. Zinn et al. [28] also
suggested that classic Langer mesomelic dysplasia may be
uncommon because most deletions extend to contiguous genes,
resulting in additional phenotypes such as developmental delay.
They reason that, as none of their patients had congenital
anomalies apart from their skeletal features, and none had
Figure 5. Composite overview of GFP expression patterns induced by shox CNE9. Expression pattern for human CNE9 at day 2 (n=41/119)
and at day 3 (n=39/109). Expression pattern in Fugu CNE9 at day 2 (n=37/93) and at day 3 (n=33/91). F=Forebrain, M=Midbrain, H=Hindbrain,
SC=Spinal cord, ON=Other Neurons, Ey=Eye, Ea=Ear, N=Notochord, M=Muscle, B=Blood, H=Heart, S=Skin, F=Fin, O=Other.
doi:10.1371/journal.pone.0021498.g005
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system, its extra skeletal functions are redundant with other genes;
perhaps SHOX2 or other HOX genes.
Interestingly, our results indicate that some shox CNEs are
duplicated at the shox2 locus. One of the more interesting
evolutionary features of shox is that it is missing in the rodent
lineage. Looking at the anatomy of rodents, they have elongated
feet rather than long bones. A possible explanation may be that
shox2 is required for limb development, while shox is required for
the regulation of limb extension. Indeed, absence of shox may
explain the relatively short leg length common to the rodents. In
human, both SHOX and SHOX2 are expressed in the limbs but as
discussed in the introduction they have subtly different patterns.
shox2 in zebrafish is expressed in early diencephalon and otic
vesicle, then hindbrain neurons and cranial ganglia tegmentum
and tectum, ventral hindbrain neurons in subventricular zone
and in marginal zone, cranial ganglia and pectoral fin (ventral
part and AER) [31] while mutations in the shox2 gene have
resulted in heart abnormalities [32]. It is of note that in zebrafish,
Sabherwal CNE9 drives strong brain and spinal cord expression
and Sabherwal CNE5 drives heart expression. Both these CNEs
have homologous sequences at the shox2 locus, a gene that shows
expression in the brain and heart, suggesting a similar role for
these CNEs in regulating shox2, a role that may also be conserved
in rodents. In addition a recent paper by Vickerman et al has
shown that the muscles of SHOX2 mutant mice show severe
developmental abnormalities. This might explain why we see
muscle expression in our analysis [33] although the CNE with the
majority of muscle expression, CNE6, is not one that is
duplicated at the shox2 locus. SHOX has been shown to be
expressed in muscle in both human and mouse [2,7] but no
muscle expression is seen in our zebrafish in situ data. It is unclear
why this is the case but might be the due to the early
developmental stages used for the in situs. In both mouse and
human, expression of SHOX in the muscle was not reported until
later stages of development.
More recently Durand et al. [34] analysed enhancer elements
upstream of the SHOX gene using chick electroporated cornea as a
comparison with the chick limb. They showed a lack of expression
in the cornea, while there was expression of these elements in the
limb bud. Parts of four of these regions correspond to CNEs
identified through Fugu : mammal comparisons, two of which we
screened in whole zebrafish embryos. For CRCNE00011089,
corresponding to Durand’s CNE2, we observed expression in the
forebrain and retina. For CRCNE00011082, corresponding to
Durand’s CNE5, we observed reporter expression in the ear [34].
Figure 6. Composite overview of GFP expression patterns induced by shox CNE6. Expression pattern of human CNE6 at day 2 (n=37/424)
and at day 3 (n=19/410). Expression pattern in Fugu CNE6 at day 2 (n=36/103) and at day 3 (n=34/78). F=Forebrain, M=Midbrain, H=Hindbrain,
SC=Spinal cord, ON=Other Neurons, Ey=Eye, Ea=Ear, N=Notochord, M=Muscle, B=Blood, H=Heart, S=Skin, F=Fin, O=Other.
doi:10.1371/journal.pone.0021498.g006
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Durand et al. is likely to be due to the nature of their assay while
the lack of limb expression we observe may be due to the
delineation of flanking sequence between Durand’s CNEs and
ours [34].
The methods we have employed remove CNEs from the
context of their regulatory landscape and only enhancers of
function are investigated. Hence it is possible that elements, such
as CNE6, which appears to drive little brain or CNS expression,
may act as a repressor for some parts of the brain enhanced by the
other CNEs. To understand this, a different approach and further
studies must be undertaken.
Conclusion
In conclusion we have shown that the shox gene is expressed in a
number of tissues in the developing zebrafish embryo including
fin, pharyngeal arch and brain, highlighting similarities with the
expression of this gene in human and chick. We have also
investigated where CNEs identified by Sabherwal et al drive
expression in a whole embryo system, advancing our understand-
ing of the regulatory region around this gene in an in vivo model
and thus identifying additional tissues under the regulatory control
of these CNEs. We have presented evidence that more deeply
conserved sub-sequences within Sabherwal et al.’s CNEs, may
show a more accurate representation of the function of the CNE.
Lastly we have identified shox CNEs which are duplicated at the
shox2 locus and are conserved in the rodent lineage around the
shox2 locus. These data taken together suggest an evolutionarily
important role for these CNEs in vertebrate development and will
hopefully lead to a better understanding of gene regulation and the
human short stature disorders such as Leri-Weill Dyschondros-
teosis.
Materials and Methods
Identification of CNEs around the shox gene
Multiple alignments were constructed in MLAGAN [11] of the
genomic loci surrounding the human, dog, opossum and Fugu shox
genes. 34 CNEs were identified with at greater than 65% identity
over at least 40 nucleotides. All CNEs are also identifiable in at
least chimp, chick and frog. Six of the CNEs share sequence
identity with CNEs at the shox2 locus. All data is stored in a
publicly accessible database, CONDOR [12], and can be
retrieved from http://condor.nimr.mrc.ac.uk.
Figure 7. Composite overview of GFP expression patterns induced by shox CNE7. Expression pattern of human CNE7 at day 2 (n=21/355)
and at day 3 (n=12/339). Expression pattern of Fugu CNE7 at day 2 (n=16/249) and at day 3 (n=29/227). F=Forebrain, M=Midbrain, H=Hindbrain,
SC=Spinal cord, ON=Other Neurons, Ey=Eye, Ea=Ear, N=Notochord, M=Muscle, B=Blood, H=Heart, S=Skin, F=Fin, O=Other.
doi:10.1371/journal.pone.0021498.g007
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Weassayed for enhancer activity in a method adapted from Muller
and colleagues [35] and described in the paper by Woolfe et al. [36].
The candidate enhancer elements were the six human conserved
non-coding elements that had been identified by Sabherwal et al. [10]
around the SHOX gene, three of which (CNE4, 5 and 9) had shown
enhancer activity in the chick limb. We injected these regions, and the
same regions from Fugu, into zebrafish embryos to look at their
expression in a whole embryo system. We also looked at a smaller,
more conserved element (CRCNE00011095) within the CNE4
region, using both human and Fugu DNA.
PCR
CNEs and negative controls were PCR-amplified from Fugu and
human genomic DNA. Primers were as follows: [human CNE4
Forward TTTTGCAGTGTTATGCACTCG, human CNE4
Reverse CCCCCTCTTAGTCCTGGTGT]; [human CNE5 For-
ward GCCTCCCTCGGGAGCGATTGTATCTATT, human
CNE5 Reverse CATCCTCATCCTGCCTTCGAAGGCAGAC];
[human CNE6 Forward TCGTCGTCATACTGTCACTGG,
human CNE6 Reverse TACCCTAAGCCCTTCCTTCC]; [hu-
man CNE7 Forward GAGGCTGCAGCTCACCCCGC, human
CNE7 Reverse AAACTGCACAGACCAGGTCT]; [human CNE8
Forward TCCCCTCTGAGCCTGGCAGG, human CNE8 Re-
verse CTCCATATCCCTGCAGAGAC]; [human CNE9 Forward
TCCCCCTATACTTTACTTCTTTGC and human CNE9 Re-
verse GCCTCTTGTGTCTGCAGTGT]; [Fugu CNE4 Forward
TGGTTAACGATAGATTCTTG,F u g uCNE4 Reverse GTCAT-
GTGTCATTCATTCAC]; [human CNE5 Forward GCCTCCC-
TCGGGAGCGATTGTATCTATT, human CNE5 Reverse CAT-
CCTCATCCTGCCTTCGAAGGCAGAC]; [Fugu CNE5 Forward
ATTTTTCATCGCCCTTGTTG, FuguCNE5 Reverse AACAAA-
GAGCGGGAGAGTGA]; [Fugu CNE6 Forward CCTAAATTA-
CAGTTTTCTCTTTGACTC, Fugu CNE6 Reverse TTACAG-
TTTTCTCTTTGACTC]; [Fugu CNE7 Forward ACCTCCC-
GACCTCCAAACT, Fugu CNE7 Reverse CCAACACTTTCTC-
TGTCTTTGC]; [Fugu CNE8 Forward CCACCATGTATATCT-
TATAATG,F u g uCNE8 Reverse GCACCTCCTATATATT-
TAAA]; [Fugu CNE9 Forward GTTCCATTCTCTGTCAAG-
GTCTG, Fugu CNE9 Reverse ACGCGTATGTAAATGGATC-
CTTT]. For the more conserved CRCNE00011095 region primers
were: [human CRCNE00011095 Forward ATTTGCCTTTTA-
ATGGGGTGT, human CRCNE00011095 Reverse GTCTTCAT-
TGATTCCGCAGAAAG]; [Fugu CRCNE00011095 Forward CA-
CACCTTCTCAGCCTTCCT,F u g uCRCNE00011095 Reverse
CACGGCGATTAAGTTTGTGG].
Figure 8. Composite overview of GFP expression patterns induced by shox CNE8. Expression pattern of human CNE8 at day 2 (n=33/618)
and at day 3 (n=22/589). Expression pattern of Fugu CNE8 at day 2 (n=19/117) and at day 3 (n=28/107). F=Forebrain, M=Midbrain, H=Hindbrain,
SC=Spinal cord, ON=Other Neurons, Ey=Eye, Ea=Ear, N=Notochord, M=Muscle, B=Blood, H=Heart, S=Skin, F=Fin, O=Other.
doi:10.1371/journal.pone.0021498.g008
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Element DNA or control DNA (at 150–300 ng/ml), reporter
construct DNA consisting of EGFP (Clontech, Palo Alto,
California, United States) under the control of a minimal
promoter from the mouse b-globin gene (at 25 ng/ml), and phenol
red (at 0.1%, used as a tracer) were combined and co-injected into
embryos between the one-cell stage and four-cell stage.
Screening
Any embryos developing abnormally were discarded before
screening. The embryos were treated with 1-phenyl-2-thiourea
(PTU) and screened for GFP activity on the second (approximately
26–33 hpf) and third (approximately 48–55 hpf) days of develop-
ment. GFP-expressing cells were classified according to the
following tissue categories: forebrain, midbrain, hindbrain, spinal
cord, eye, ear, notochord, muscle, blood, heart or fins. Cells that
did not fall into one of these categories (or that were not possible to
identify from morphology or localisation) were categorised as
‘‘other’’ or ‘‘unspecified’’. The location and tissue category of each
GFP-expressing cell for each embryo was recorded onto an
overlay of a camera lucida drawing of a 31 hpf and a 50 hpf
embryo. GFP expression data was collected from between 20 and
50 expressing embryos per element injected. Cumulative, overlaid,
schematised expression data for each element was compiled into a
single JPEG file, giving an overall representation of the spatial
pattern of each element. The number of cells per tissue in which
GFP expression was detected was graphed giving an indication of
the strength of the element’s enhancing properties.
In Situ hybridisation of shox gene
In Situ hybridisation of shox gene was carried out using the
Thisse’s method as published on Zfin [37]. Probes were made to
the first and last exons of the shox gene using the Thisse’s PCR
method B [37] with the following primers: [shox 1st exon Forward
AAACCCTTCTCCACGCAAA, shox 1st exon T7 Reverse
TAATACGACTCACTATAGGGAGAAGCCCTTGTCACGC-
TAA]; [shox last exon Forward AACACACTCCCATCCTCA-
CC, shox last exon T7 Reverse TAATACGACTCACTA-
TAGGGTTGTTTTGTTTTAACTGTGAGTGTCA]. Embryos
were treated with 1-phenyl-2-thiourea (PTU), manually dechor-
ionated and fixed in 4% paraformaldehyde at 24 hpf and 72 hpf.
Zebrafish care
Zebrafish embryos were obtained from sibling crosses from
adult fish housed at the fish facility at Queen Mary University of
London. Zebrafish were raised and bred and embryos staged
following standard protocols [38,39]; stages are described as the
approximate number of hours post-fertilisation (hpf) when
embryos are raised at 28.5uC. To prevent pigment formation,
embryos were raised in 0.003% phenylthiocarbamide in embryo
medium from tailbud stage.
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